Increasing Mortality Due to End-Stage Liver Disease in Patients with Human Immunodeficiency Virus Infection
Top Cited Papers
Open Access
- 1 February 2001
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 32 (3), 492-497
- https://doi.org/10.1086/318501
Abstract
Highly active antiretroviral therapy has decreased human immunodeficiency virus (HIV)-associated mortality; other comorbidities, such as chronic liveKeywords
This publication has 25 references indexed in Scilit:
- Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patientsHepatology, 1999
- Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitorsAIDS, 1998
- Natural history of hepatitis CHepatology, 1997
- Human immunodeficiency virus infection modified the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosisJournal of Hepatology, 1997
- Correlates of Hepatitis C Virus Infections among Injection Drug UsersMedicine, 1995
- HCV RNA levels and HIV infection: evidence for a viral interaction in haemophilic patientsBritish Journal of Haematology, 1994
- The progression of HCV‐associated liver disease in a cohort of haemophilic patientsBritish Journal of Haematology, 1994
- Prevalence of antibody to hepatitis C virus (HCV) in HIV-1-infected patients (nice seroco cohort)Journal of Medical Virology, 1994
- The Natural History of Community-Acquired Hepatitis C in the United StatesNew England Journal of Medicine, 1992
- Loss of antibodies against hepatitis C virus in HIV-seropositive intravenous drug usersAIDS, 1990